Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial

2021

BackgroundInflammation contributes to unstable atherosclerotic plaque and stroke. In randomised trials in patients with coronary disease, canukinumab (an interleukin-1B antagonist) and colchicine (...

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

29

References

3

Citations